SOP for Addressing Stability Issues in ANDA Submissions to the US FDA
SOP for Addressing Stability Issues in ANDA Submissions to the US FDA Standard Operating Procedure for Handling Stability Issues in ANDA Submissions 1) Purpose The purpose of this SOP is to establish a procedure for addressing stability issues in Abbreviated New Drug Applications (ANDA) submissions to the US FDA to ensure compliance with regulatory requirements….
Read More “SOP for Addressing Stability Issues in ANDA Submissions to the US FDA” »